Abstract:

Preeclampsia risk is a global pandemic that poses a serious threat to global health. It is recognized as a chronic and debilitating disease that is associated with significant complications. As a result, it significantly reduces life expectancy, can cause multi-system morbidities, increases healthcare costs, and ultimately results in the premature death of both the mother and the fetus. All forms of preeclampsia carry unacceptable human, societal, and financial costs for Imo State, regardless of income. Therefore, in Imo State, Southeast Nigeria, this study looked into the socioeconomic effects of the risks associated with pre-eclampsia during pregnancy. This study employed both descriptive and analytical study designs. Data gathering techniques included target, stratified sampling, and random sampling. A total of 3690 people from around the state made up the sample size. Questionnaires were used as the research tool for data collection. Tables and charts with the generated data were created. Statistically descriptive:. The significant difference between the perception of risk variables by individuals and patients was measured using chi-square. Regarding the socioeconomic effects of preeclampsia risks, respondents were generally in agreement that these risks can result in job loss, with 56.19%, or 1190 out of 2700 responses, saying “Yes,” 12.84%, or 272 out of 2700 responses, saying “No,” and 656 out of 2700 respondents, or 30.97% of the responses, saying “No idea.” However, there was a very high significant variation among their responses. Additionally, they agreed that preeclampsia risks can result in subpar performance at work. Preeclampsia risks had a negative socioeconomic influence on the patients’.

References:

[1] Vidaeff A, Pettker CM, Simhan H. (2019) Gestational Hypertension and Preeclampsia ACOG PRACTICE BULLETIN. Clinical Management Guidelines for Obstetrician-Gynecologists. Am Coll. Obstet Gynecol. 133(1):1–25 7.3. Williams PJ and Broughton Pipkin F (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 25: 405-417.

[2] Trogstad L, Magnus P, Stoltenberg C (2011).. Pre-eclampsia: Risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 25(3):329-42.

[3] Williams PJ and Broughton Pipkin F (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 25: 405-417

[4] Belay A.S., Wudad T. (2019). Prevalence and associated factors of pre-eclampsia among pregnant women attending antenatal care at Mettu Karl referral hospital, Ethiopia: cross-sectional study. Journal of Clinical Practice, 25(1):14.

[5] World Health Organisation’ (2011). WHO recommendations for prevention and treatment of preeclampsia and eclampsia. Available at: https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548335/en/ (Accessed: 8 January 2021).

[6] Bellamy, L, Casas, J, Hingorani, AD, Williams, DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. British Medical Journal. 2007; 335:974–985.

[7] Birhanu MY, Temesgen H, Demeke G, Assemie MA, Alamneh AA, Desta M, Toru M, Ketema DB, Bischof P, Martelli M, Campana A, Itoh Y, Ogata Y, Nagase H. (1995) Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 263-269.

[8] Stevens W, Shih T, Incerti D, Ton TGN, Lee HC, Peneva D, (2017) Short-term costs of preeclampsia to the United States health care system. Am J Obstet Gynecol. ;217(3):237–248.e16.

[9] Nnodim, J., Emmanuel, N., Hope, O., Nwadike, C., Ukamaka, E., Christian, O. (2017). Membrane potential, serum calcium and serum selenium decrease in pre-eclampsia subjects in Owerri. Universa Medicina, 36(2), 88–93.

[10] Siddiqui A, Deneux-Tharaux C, Luton D, Schmitz T, Mandelbrot L, Estellat C (2020) Maternal obesity and severe pre-eclampsia among immigrant women: a mediation analysis. Sci Rep.;10(1):1–9.

[11] Ajah L.O., Ozonu N.C., Ezeonu P.O., Lawani L.O., Obuna J.A., Onwe E.O. (2016). The Feto-Maternal Outcome of Preeclampsia with Severe Features and Eclampsia in Abakaliki, South-East Nigeria. Journal of Clinical Diagnostics and Research, 10(9): QC18–QC21.

[12] Amaral LM, Wallace K, Owens M, LaMarca B (2017). Pathophysiology and Current Clinical Management of Preeclampsia. Curr Hypertens Rep. 19(8):616.

[13] Gray KJ, Kovacheva VP, Mirzakhani H, Bjonnes AC, Almoguera B, Wilson ML, Ingles SA, Lockwood Hakonarson H, McElrath TF, Murray JC, Norwitz ER, Karumanchi SA, Bateman BT (2018), Gene-Centric Analysis of Preeclampsia Identifies Maternal Association at PLEKHG1 Hypertension, ;72(2):408-416.

[14] Morton CH, Seacrist MJ, VanOtterloo LR, Main EK. (2019) Quality improvement opportunities identified through case review of pregnancy-related deaths from preeclampsia/eclampsia. J Obstet Gynecol Neonatal Nurs. 48(3):275–87.

[15] Berhan Y., Endeshaw G. (2015). Clinical and Biomarkers Difference in Prepartum and Postpartum Eclampsia. Ethiopian Public Health Journal, 25(3):257–66.

[16] Das S, Das R, Bajracharya R, Baral G, Jabegu B, Odland JØ, (2019) Incidence and risk factors of pre-eclampsia in the paropakar maternity and women’s hospital, Nepal: A retrospective study. Int J Environ Res Public Health. 16(19):1–8.

[17] Ebrahimi A, Sayad B, Rahimi Z. (2020) COVID-19 and psoriasis: biologic treatment and challenges. J Dermatolog Treat. J Dermatolog Treat; 1–5.

[18] Aziza.com.ng (2022). Imo State History, Local Government Area, and Senatrial Zones/Districts. Available at: https://www.aziza.com.ng/read/2019/10/imo-state-and-local-government-area/ (Accessed: 9 January 2022).

[19] Lucas, A. O. and Gilles, H. M. (2003): Short textbook of public health medicine for the tropics. Revised 4th edition. Hodder Arnold, London, UK pp 30-51.

[20] Farmer, A.; Wade, A. and Goyder, E. (2007): Impact of self-monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ.;335:132.

[21] Payne, R. W., Murray, D. A., Hardings, S. A. Baird, D. B. and Soutar, D. M. (2007). GenStat for windows (12th Edition). VSN International Ltd, Hemel Hempstead.

[22] Wandabwa J., Doyle P., Kiondo P., Campbell O., Maconichie N., Welishe G. (2010). Risk factors for severe pre-eclampsia and eclampsia in Mulago Hospital, Kampala, Uganda. East African Medical Journal, 87(10):415–24.